BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, January 16, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for Sept. 29, 2020

Sep. 29, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acasti, Aclipse, Advaxis, Annovis, Arbor, Aspargo, Baselaunch, Better Plant, CASI, Celyad, Creative Medical, Cristal, Enesi, EV, Farmalider, Field Trip Psychedelics, Fosun, Global Cancer Technology, J&J, Juventas, Koligo, Lexaria, Lifesci Acquisition, Luca, M8, Merck, Moleculin, Navrogen, Neuropore, Orgenesis, Polyphor, Psygen, Sema4, Soricimed, Sorrento, South Rampart, Tonix, Vincera, Vor.
Read More

In the clinic for Sept. 29, 2020

Sep. 29, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Algernon, Arcutis, Artelo, Ascendis, Basilea, Beyondspring, Citius, Concert, Forte, Inversago, J&J, Junshi, Kaleido, Kuur, Medincell, Myovant, Ocular Therapeutix, Revive, Veru, Zucara.
Read More

Financings for Sept. 29, 2020

Sep. 29, 2020
Biopharmas raising money in public or private financings, including: Aegle, Axsome, Aztherapies, Beam, Dewpoint, Duopharma, Geovax, Merck, Orphazyme, Paxmedica, Synklino, Taysha Gene, Turmeric.
Read More

Appointments and advancements for Sept. 29, 2020

Sep. 29, 2020
New hires and promotions in the biopharma industry, including: Alivio, Anokion, Aziyo, Black Diamond, Brainstorm Cell, Deep Genomics, Immatics, Mina, Montis, Trisalus, Xilio.
Read More

Regulatory actions for Sept. 28, 2020

Sep. 28, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Hologic, Masimo, Quotient, Zymo Research.
Read More

Other news to note for Sept. 28, 2020

Sep. 28, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Angle, Endpoint Health, Fibrogenesis, Handsfree Health, Ibiologics, Stryker.
Read More

In the clinic for Sept. 28, 2020

Sep. 28, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Curetis, Opgen.
Read More

Financings for Sept. 28, 2020

Sep. 28, 2020
Med-tech firms raising money in public or private financings, including: Cognoptix, Goodrx, Hyprevention, Varex Imaging.
Read More

Appointments and advancements for Sept. 28, 2020

Sep. 28, 2020
New hires and promotions in the med-tech industry, including: Biocom, Ellipsis Health, Jenavalve.
Read More

Regulatory actions for Sept. 28, 2020

Sep. 28, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Aligos, Apollomics, Aquestive, Avrobio, Biomed Valley, Cipla, CSL, FSD, Gilead, Glaxosmithkline, Heron, Huya, Inceptua, Inovio, Khondrion, Orchard, Shionogi, Stemedica, Xcures.
Read More
Previous 1 2 … 1460 1461 1462 1463 1464 1465 1466 1467 1468 … 1738 1739 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 16, 2026.
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Businesswoman pressing dollar sign on touchscreen

    JPM 2026: Year kicks off with biopharma Q4 revenue and guidance

    BioWorld
    It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing